| Registry | NCT02258906 |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, prevention |
| Enrollment | 66 (Actual) |
| Sponsor | Yonsei University (Other) |
| Conditions | Renal Mass |
| Interventions | ulinastatin, normal saline (Drug) |
| Dates | start 2014-10-01, primary completion 2016-07-01, completion 2016-07-01, first posted 2014-10-08, last updated 2016-08-25 |
| Locations | 1 site in South Korea |
Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Renal Mass All trials of ulinastatin All trials of normal saline
Ulinastatin reduces systemic inflammatory responses and protects organs from ischemia/reperfusion-induced injury. The aim of this study is to evaluate the effect of ulinastatin on postoperative renal function in patients undergoing robot-assisted laparoscopic partial nephrectomy. Seventy patients, aged 20 to 79 years, scheduled for robot-assisted laparoscopic partial nephrectomy will be divided into ulinastatin (n=35) and control (n=35) groups. Randomly selected patients of the ulinastatin group are given ulinastatin. In contrast, patients in the control group receive an equivalent volume of normal saline as a placebo. The primary endpoints are postoperative renal function measured by serum creatinine, cystatin C, and urine output.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Ulinastatin group | Experimental | Drug: ulinastatin | Patients in the ulinastatin group are given ulinastatin during operation. |
| control group | Placebo comparator | Drug: normal saline | Patients in the control group receive the same volume of normal saline during operation. |
Sex: All, ages: 20 Years to 79 Years
Inclusion Criteria: * patients who are scheduled to undergo robot-assisted laparoscopic partial nephrectomy with an American Society of Anesthesiologists (ASA) physical status I-III Exclusion Criteria: * Subjects are ineligible if they have severe respiratory or cardiovascular disease, renal insufficiency before operation, cognitive dysfunction, are unable to communicate or speak Korean
| Facility | City | Country | Status |
|---|---|---|---|
| Severance Hospital, Yonsei University College of Medicine | Seoul | South Korea |